The intervention trial of safety and efficacy of once-weekly Trelagliptin switched from daily DPP4 inhibitors for elderly patients with type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000026319
- Lead Sponsor
- Kanagawa-ken Keiyu-kai Keiyu hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with renal dysfunction [creatinine clearance <50 ml/min or serum creatinine above 1.4 mg/dl(male), 1.2 mg/dl(female)] Patients using insulin or GLP-1 receptor agonists
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evels of glycohemoglobin at before and 12 weeks after switching
- Secondary Outcome Measures
Name Time Method Blood pressure, abdominal circumference, weight,frequency and severity of hypoglycemia, liver function, renal function